We’re proud to share that the FDA has granted #OrphanDrug designation to NS-229 for the treatment of #EGPA — a rare autoimmune disease that affects fewer than 200,000 people in the U.S!
Check out the press release: https://ow.ly/zYkj50VEL8x
We’re thrilled to welcome Tanya as our new Director of Supply Chain!
With 20+ years of experience in pharma, she brings a wealth of expertise in leading and shaping global clinical and commercial #SupplyChain operations.